Triple Therapy Halves Exacerbations In Moderate-To-Severe COPD, Hannover Medical School Study
EurekAlert! -- Patients with moderate to severe chronic obstructive pulmonary disease (COPD) can benefit from triple therapy that includes a long-acting ß-agonist (LABA), an inhaled corticosteroid (ICS) and an anti-muscarinic agent, according to researchers in Germany.